David S Carter
Overview
Explore the profile of David S Carter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Combs J, Carter D, Gu F, Jin X, Martin C, Resendiz E, et al.
Org Lett
. 2023 Nov;
25(45):8083-8088.
PMID: 37922494
Rhodium(II) catalyzes carbene transfer from trimethylsilyldiazomethane to arylmethyl thioethers, generating sulfonium ylides that undergo [2,3]-sigmatropic rearrangement, punching quaternary centers into aromatic rings. The reaction works well with naphthalene, indole, and...
2.
Padilla A, Wang W, Akama T, Carter D, Easom E, Freund Y, et al.
Nat Microbiol
. 2022 Sep;
7(10):1536-1546.
PMID: 36065062
Trypanosoma cruzi, the agent of Chagas disease, probably infects tens of millions of people, primarily in Latin America, causing morbidity and mortality. The options for treatment and prevention of Chagas...
3.
Akama T, Freund Y, Berry P, Carter D, Easom E, Jarnagin K, et al.
ACS Infect Dis
. 2019 Dec;
6(2):173-179.
PMID: 31876154
A series of benzimidazole-benzoxaborole hybrid molecules linked via an amide linker are described that exhibit good activity against , a filarial nematode responsible for the disease onchocerciasis, also known as...
4.
Carter D, Jacobs R, Freund Y, Berry P, Akama T, Easom E, et al.
ACS Infect Dis
. 2019 Dec;
6(2):180-185.
PMID: 31876143
The optimization of a series of benzimidazole-benzoxaborole hybrid molecules linked via a ketone that exhibit good activity against , a filarial nematode responsible for the disease onchocerciasis, also known as...
5.
Robertson G, Ektnitphong V, Scherman M, McNeil M, Dennison D, Korkegian A, et al.
Antimicrob Agents Chemother
. 2019 Feb;
63(4).
PMID: 30745397
AN12855 is a direct, cofactor-independent inhibitor of InhA in In the C3HeB/FeJ mouse model with caseous necrotic lung lesions, AN12855 proved efficacious with a significantly lower resistance frequency than isoniazid....
6.
Jacobs R, Lunde C, Freund Y, Hernandez V, Li X, Xia Y, et al.
J Med Chem
. 2019 Feb;
62(5):2521-2540.
PMID: 30730745
A series of pleuromutilins modified by introduction of a boron-containing heterocycle on C(14) of the polycyclic core are described. These analogs were found to be potent anti- Wolbachia antibiotics and,...
7.
Xia Y, Zhou Y, Carter D, McNeil M, Choi W, Halladay J, et al.
Life Sci Alliance
. 2018 Nov;
1(3):e201800025.
PMID: 30456352
New antitubercular agents are needed to combat the spread of multidrug- and extensively drug-resistant strains of . The frontline antitubercular drug isoniazid (INH) targets the mycobacterial enoyl-ACP reductase, InhA. Resistance...
8.
Korkegian A, OMalley T, Xia Y, Zhou Y, Carter D, Sunde B, et al.
Tuberculosis (Edinb)
. 2018 Mar;
108:96-98.
PMID: 29523334
We identified a series of novel 7-phenyl benzoxaborole compounds with activity against Mycobacterium tuberculosis. Compounds had a range of activity with inhibitory concentrations (IC) as low as 5.1 μM and...
9.
Talamas F, Abbot S, Anand S, Brameld K, Carter D, Chen J, et al.
J Med Chem
. 2013 Nov;
57(5):1914-31.
PMID: 24195700
In the past few years, there have been many advances in the efforts to cure patients with hepatitis C virus (HCV). The ultimate goal of these efforts is to develop...
10.
Lucas M, Weikert R, Carter D, Cai H, Greenhouse R, Iyer P, et al.
Bioorg Med Chem Lett
. 2010 Aug;
20(18):5559-66.
PMID: 20691589
Two new series of monoamine triple reuptake inhibitors (TRIs) have been discovered through scaffold homologation of our recently reported series of 3,3-disubstituted pyrrolidine TRIs. The regioisomeric 2- and 3-ketopyrrolidines demonstrated...